You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -442.4% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -7.7 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 31.2 | n/a |
| Price / Book value | 4.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 107.5% | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 1.70 | -3.51 | -17.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 1.16 | -6.95 | -27.00p | -14.8 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 2.40 | -10.54 | -32.00p | -7.5 | 0.0 | n/a | n/a | 0.0% |
| Arecor Therapeutics appoints new chief business officer Sharecast News | 05 Apr |
|---|---|
| Arecor Therapeutics begins type-2 diabetes trial Sharecast News | 22 Mar |
| Arecor granted three patents in US, India Sharecast News | 16 Feb |
| Director/PDMR Shareholding | 24-May-23 14:43 |
|---|---|
| ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM | 04-May-23 23:58 |
| Arecor Granted Key U.S Patent | 26-Apr-23 15:31 |
| Unaudited Preliminary Results for 2022 | 20-Apr-23 14:54 |
| Arecor Appoints Chief Business Officer | 05-Apr-23 14:37 |